GlassScriptPhysician profile
Consuelo Alanis
NPI 1740873710
$3,645.62
in general payments reported to CMS, 2019-2025
20 companies · $575 in 2025
The $575 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $695 · 2023: $1,065 · 2024: $1,310 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,950.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,789.19 | 2022-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Abbvie INC. | $393.11 | 2022-2025 | |
| Novo Nordisk INC | $341.46 | 2022-2025 | Sogroya, Norditropin, Wegovy |
| Ascendis Pharma Endocrinology INC | $295.44 | 2024-2025 | Skytrofa |
| Insulet Corporation | $123.79 | 2022-2025 | Omnipod |
| Kyowa Kirin, INC. | $93.00 | 2023-2025 | Crysvita |
| Azurity Pharmaceuticals, INC. | $77.73 | 2023-2024 | Triptodur, Triptodur |
| Xeris Pharmaceuticals, INC. | $68.81 | 2022-2025 | Gvoke Hypopen |
| Neurocrine Biosciences, INC. | $61.21 | 2024-2025 | |
| Tolmar, INC. | $60.19 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $51.97 | 2022 | |
| Alexion Pharmaceuticals, INC. | $49.30 | 2022-2025 | Strensiq |
| Eton Pharmaceuticals, INC. | $47.57 | 2023-2024 | Alkindi |
| Dexcom, INC. | $45.05 | 2023 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $44.11 | 2025 | Dupixent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $27.31 | 2024 | Voxzogo 1.2mg |
| Paratek Pharmaceuticals, INC. | $19.98 | 2025 | Xhance |
| Intuity Medical INC | $19.31 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Phadia US INC. | $18.80 | 2025 | Immunocap |
| Tandem Diabetes Care, INC. | $18.29 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Consuelo Alanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.